CATALOGO DEI PRODOTTI DELLA RICERCA

LUPO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.209
EU - Europa 12.343
AS - Asia 8.931
SA - Sud America 1.245
Continente sconosciuto - Info sul continente non disponibili 289
AF - Africa 165
OC - Oceania 21
Totale 37.203
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.988
RU - Federazione Russa 4.088
SG - Singapore 3.746
GB - Regno Unito 2.948
CN - Cina 2.621
BR - Brasile 1.008
IT - Italia 1.001
SE - Svezia 929
VN - Vietnam 768
DE - Germania 756
FR - Francia 745
IE - Irlanda 681
FI - Finlandia 657
HK - Hong Kong 646
KR - Corea 316
UA - Ucraina 219
BD - Bangladesh 206
IN - India 122
CA - Canada 102
AR - Argentina 92
JP - Giappone 76
ID - Indonesia 66
TR - Turchia 62
MX - Messico 54
IQ - Iraq 53
BE - Belgio 50
NL - Olanda 46
AT - Austria 41
NG - Nigeria 41
EC - Ecuador 38
ZA - Sudafrica 38
ES - Italia 34
PL - Polonia 32
CO - Colombia 28
IL - Israele 25
VE - Venezuela 24
UZ - Uzbekistan 23
MA - Marocco 22
PK - Pakistan 22
AU - Australia 19
PY - Paraguay 18
EG - Egitto 17
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 16
CL - Cile 16
MY - Malesia 14
PH - Filippine 14
CZ - Repubblica Ceca 13
TH - Thailandia 13
AZ - Azerbaigian 12
JM - Giamaica 12
EU - Europa 11
LT - Lituania 11
GR - Grecia 10
JO - Giordania 10
KZ - Kazakistan 10
TN - Tunisia 10
CH - Svizzera 9
HN - Honduras 9
RO - Romania 9
BH - Bahrain 8
CR - Costa Rica 8
KE - Kenya 8
NP - Nepal 8
PA - Panama 8
BO - Bolivia 7
HR - Croazia 7
NI - Nicaragua 7
PE - Perù 7
RS - Serbia 7
AL - Albania 6
DK - Danimarca 6
IR - Iran 6
KG - Kirghizistan 6
OM - Oman 6
PS - Palestinian Territory 6
PT - Portogallo 6
DO - Repubblica Dominicana 5
ET - Etiopia 5
KH - Cambogia 5
LV - Lettonia 5
SN - Senegal 5
UY - Uruguay 5
BG - Bulgaria 4
CG - Congo 4
DZ - Algeria 4
HU - Ungheria 4
LB - Libano 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AM - Armenia 3
BB - Barbados 3
BY - Bielorussia 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 36.890
Salva come PNG Salva come JPEG
Città #
Southend 2.455
Singapore 1.990
Jacksonville 1.892
Ashburn 1.444
Chandler 1.442
Moscow 1.246
San Jose 1.152
Woodbridge 901
Dallas 799
Ann Arbor 714
Dublin 678
Hong Kong 638
Houston 546
Verona 400
Beijing 379
The Dalles 378
Wilmington 285
Lawrence 268
Princeton 268
New York 251
Council Bluffs 239
Los Angeles 210
Jinan 198
Ho Chi Minh City 196
Nanjing 173
Shenyang 166
Buffalo 163
Hanoi 147
Helsinki 132
Boardman 119
Tianjin 115
Hebei 106
Santa Clara 104
Dong Ket 101
São Paulo 98
Sindelfingen 89
Milan 87
Columbus 86
Tokyo 72
Ningbo 66
Changsha 64
Haikou 63
Orem 63
Guangzhou 62
Zhengzhou 62
Redondo Beach 61
Nanchang 58
Munich 55
Jiaxing 52
Seattle 51
Brussels 50
Hangzhou 50
Lancaster 47
Chicago 45
Taizhou 44
Falls Church 41
Seoul 41
Abuja 39
San Francisco 39
Rome 38
Taiyuan 38
Jakarta 37
Philadelphia 36
Rio de Janeiro 35
Norwalk 34
Lanzhou 33
London 32
Toronto 31
Atlanta 29
Chennai 29
Montreal 29
Nuremberg 29
Washington 29
Turku 28
Brooklyn 27
Frankfurt am Main 27
Auburn Hills 26
Denver 26
Phoenix 26
Vienna 26
Warsaw 26
Detroit 24
Kent 23
Da Nang 22
Haiphong 22
Baghdad 21
Johannesburg 21
Quito 21
Redmond 21
Amsterdam 20
Fairfield 20
Fuzhou 20
Mumbai 18
Redwood City 18
Venice 18
Belo Horizonte 17
Biên Hòa 17
Bologna 17
Shanghai 17
Tashkent 17
Totale 22.825
Salva come PNG Salva come JPEG
Nome #
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 294
125I-iothalamate and creatinine clearances in patients with chronic renal diseases 288
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 260
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 259
Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: relations to dialysis treatments, diet and cardiovascular complications 250
Adding access blood flow surveillance to clinical monitoring reduces thrombosis rates and costs, and improves fistula patency in the short term: a controlled cohort study. 226
Endovascular versus Surgical Preemptive Repair of Forearm Arteriovenous Fistula Juxta-Anastomotic Stenosis: Analysis of Data Collected Prospectively from 1999 to 2004 220
Cutaneous plasmacytoma in a hemodialysis patient. 212
Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. 212
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. 211
A napkin-associated outbreak of Burkholderia cenocepacia bacteraemia in haemodialysis patients. 211
Terapia della glomerulonefrite membrano proliferativa. 210
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 209
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 208
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 206
A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: Teicoplanin plus tobramycin versus cephalothin plus tobramycin 205
Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study 205
14-year experience with the double-cuff straight Tenckhoff catheter 204
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 202
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 198
Alterations in renal tubular sodium and water transport in polycystic kidney disease 197
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. 197
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 197
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 196
Outcomes of the surgical revision of stenosed and thrombosed forearm arteriovenous fistulae for hemodialysis 194
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? 189
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 188
Aspects of calcium metabolism in obstructive nephropathy: a metabolic and bone biopsy investigation 186
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 186
mTOR inhibitors and renal allograft: Yin and Yang. 185
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 184
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 184
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 184
Everolimus-associated interstitial pneumonia in a renal transplant patient: a case report 183
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 183
99mTc-Ca-gluconate renal scintigraphy in patients with chronic renal failure 182
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 181
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 181
La qualità della vita nell’anziano in dialisi [Quality of life of the elderly patient on dialysis]. 180
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 180
An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. 179
Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study. 179
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 179
The impact of pruritus on quality of life of patients undergoing dialysis: A single-center cohort study 178
Acute changes in renal function in IgA nephropathy 174
Bedside Screening for Fistula Stenosis Should Be Tailored to the Site of the Arteriovenous Anastomosis 174
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. 174
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 173
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 173
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 172
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 171
Assessment of physical performance and body composition in male renal transplant patients 171
In search of an optimal bedside screening program for arteriovenous fistula stenosis 171
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 170
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 169
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 169
3 years' experience in the prevention of recurrent calcic nephrolithiasis 168
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. 167
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 167
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 166
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 166
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 165
GDNF gene Variants Associated with Medullary Sponge Kidney. Distinguish a Specific Clinical Phenotype. 164
Carbohydrate metabolism in patients with nephrotic syndrome and normal renal function 163
A validated model of disease progression in IgA nephropathy. 163
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 163
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 163
Altered thyroid in dialysed uremic patients 162
Rapporti tra adattamento, qualità di vita e supporto familiare, sociale nel paziente in trattamento dialitico. [Dialysis, adaptation, quality of life, and family support.] 162
Unusual renal presentation of Fabry disease in a female patient. 162
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 160
ENDOTHELIAL PROGENITOR CELLS IN ACUTE RENAL INJURY 159
Practice patterns in the management of arteriovenous fistula stenosis: a northern Italian survey. 159
Antihypertensive, hemodynamic and endocrine effects of Captopril in arterial hypertension 158
Post-renal transplant pregnancy: a project to plan carefully 158
Mitochondria: a new therapeutic target in chronic kidney disease. 158
mTOR Inhibition Role in Cellular Mechanisms 158
Renal lesions after unilateral ureterosigmoidostomy in the rabbit: preliminary results 157
Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Italian Cooperative Peritoneal Dialysis Study Group 155
Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience. 155
Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): A Padua Medical School discovery in the 1930s. 154
Procalcitonin values after dialysis is closely related to type of dialysis membrane 153
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 153
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 153
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 153
Cutaneous plasmacytoma in a hemodialysis patient. 152
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 152
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. 152
Red blood cells and platelet membrane fatty acids in non-dialyzed and dialyzed uremics 151
Basi scientifiche per la definizione di linee guida in ambito clinico per i tumori della prostata 151
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation. 151
Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial 151
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 149
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 149
Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure 148
Renal tubular defects in recurring bilateral nephrolithiasis 148
Effects of high doses of frusemide on plasma and muscle electrolytes in patients with chronic renal failure 148
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 147
Atherosclerosis and cardiovascular risk factors in CAPD 146
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. 146
Totale 17.888
Salva come PNG Salva come JPEG
Categoria #
all - tutte 125.090
article - articoli 114.325
book - libri 0
conference - conferenze 4.975
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.790
Totale 250.180
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.581 0 363 18 178 64 52 39 113 88 50 150 466
2022/20234.371 328 426 471 662 419 1.100 53 267 444 23 121 57
2023/20241.717 99 176 163 198 235 231 27 117 16 76 261 118
2024/20254.810 312 351 174 825 225 160 194 269 729 290 375 906
2025/202613.623 1.060 696 913 2.121 3.199 961 1.435 754 899 784 351 450
2026/2027273 218 55 0 0 0 0 0 0 0 0 0 0
Totale 37.203